Table 2.
Baseline clinical characteristics of participants at the National Cheng Kung University Hospital (NCKUH) and patients with localized prostate cancer registered in the Taiwan Cancer Registry (TCR).
| NCKUH (n = 196) |
TCR (n = 31,183) |
p | |
|---|---|---|---|
| Age at diagnosis, mean (SD) years | 68.24 (7.00) | 72.82 (9.16) | <0.01 |
| Comorbidities, n (%) | |||
| Cardiovascular disease | 34 (17) | 6667 (21) | 0.17 |
| Hypertension | 89 (45) | 15,968 (51) | 0.10 |
| Diabetes | 40 (20) | 5610 (18) | 0.38 |
| Arthritis | 22 (11) | 48 (0.1) | <0.01 |
| Anxiety/depression | 18 (9) | 2742 (9) | 0.84 |
| Peptic ulcer | 23 (12) | 4215 (14) | 0.46 |
| Risk group a, n (%) b | |||
| Low | 43 (22) | 3983 (25) | 0.62 |
| Intermediate | 72 (37) | 5643 (35) | |
| High | 81 (41) | 6321 (40) | |
| Primary prostate treatment, n (%) b | |||
| Radical prostatectomy | 104 (53) | 12,942 (46) | 0.11 |
| Radiotherapy | 37 (19) | 5311 (19) | |
| Active surveillance | 55 (28) | 9670 (35) |
Patients were diagnosed with prostate cancer in NCKUH from 2009 to 2017 and in TCR from 2009 to 2016. a Prostate cancer risk group information in TCR was limited to 2012–2016 because of availability. b Patients with incomplete information on risk group or primary prostate cancer treatment were not analyzed in the statistics. SD, standard deviation.